CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
更正：週五，Unicycive Therapeutics公佈的第四季度每股收益爲0.22美元（0.22美元），未達到預期（0.17美元）
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the same period last year.
Unicycive Therapeutics（納斯達克股票代碼：UNCY）公佈的季度虧損爲每股0.22美元，比分析師普遍預期的0.17美元（0.17美元）低29.41％。與去年同期每股虧損0.51美元（0.51美元）相比，增長了56.86％。